Multiple Sclerosis and Related Disorders

SJR Rank #5,225H-index: 77SJR: 0.959Best quartile: Q1APC: US$3,500
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q1
  • NeurologyQ2
  • Neurology (clinical)Q2

Areas: Medicine · Neuroscience

Most published research topics

Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSystemic Sclerosis and Related DiseasesPolyomavirus and related diseasesAmyotrophic Lateral Sclerosis ResearchLong-Term Effects of COVID-19Systemic Lupus Erythematosus ResearchBalance, Gait, and Falls PreventionAutoimmune Neurological Disorders and TreatmentsRheumatoid Arthritis Research and Therapies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs045090013501800

Documents per Year

202220250200400600800

Detailed Information

ISSN

2211-0356, 2211-0348

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.82

References per Document

39.48

Coverage

2012-2026

Scope

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource. A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.

Metrics from SCImago Journal Rank 2025. View on SCImago